U.S. Senator Elizabeth Warren | Warren Urges FTC to Prote...
In October 2024, Senator Elizabeth Warren (D-Mass.) urged the FTC to closely scrutinize the Novo Nordisk-Catalent merger and to block it if it violated antitrust law.
U.S. Senator Elizabeth Warren | Warren to FTC: Closely Sc...
Mar 22, 2023 · Washington, D.C. - United States Senator Elizabeth Warren (D-Mass.) sent a letter to FTC Chair Lina Khan and Commissioners Alvaro Bedoya and Kelly Slaughter urging them to carefully scrutinize CVS Health Corp’s (CVS) pending acquisition of Oak Street Health, Inc …
U.S. Senator Elizabeth Warren | Warren Urges FTC To Close...
Oct 10, 2024 · Washington, DC – U.S. Senator Elizabeth Warren (D-Mass.) sent a letter to Federal Trade Commission (FTC) Chair Lina Khan, urging the FTC to closely scrutinize a proposed merger between Novo Nordisk and contract development and manufacturing organization Catalent, and block the deal if it is found to be illegal under antitrust law. In the ...
Warren wants close FTC scrutiny of drug distributors buying …
Oct 29, 2024 · Sen. Elizabeth Warren (D-Mass.) is urging the Federal Trade Commission to scrutinize recent deals from McKesson and Cardinal Health to buy oncology practices, saying those transactions pose...
U.S. Senator Warren 'particularly concerned' about Amgen
Jan 26, 2023 · WASHINGTON (Reuters) -Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical...
Warren slams legal challenges to FTC noncompete ban
Aug 1, 2024 · Sen. Elizabeth Warren (D-Mass.) voiced her support for the Federal Trade Commission's ban on noncompete agreements and said she believes ongoing legal efforts to roll back the rule are wrong. The ban, which is set to take effect Sept. 4, has so far faced legal challenges in Texas and Pennsylvania.
Sen. Elizabeth Warren wants FTC to scrutinize Novo Nordisk deal …
Elizabeth Warren (D-MA) is calling on the Federal Trade Commission to carefully evaluate Novo Nordisk Foundation's planned $16.5 billion acquisition of Catalent (NYSE: CTLT).
Warren calls on the FTC to scrutinize to Big Pharma mergers
Jan 30, 2023 · Late last week, Massachusetts Sen. Elizabeth Warren called on the Federal Trade Commission to put a magnifying glass on a pair of pending Big Pharma mergers.
Sen. Elizabeth Warren wants FTC to scrutinize Novo Nordisk deal …
Oct 10, 2024 · Sen. Elizabeth Warren (D-MA) is calling on the Federal Trade Commission to carefully evaluate Novo Nordisk Foundation's planned $16.5 billion acquisition of Catalent (NYSE:CTLT).
Lawmaker asks FTC to probe Novo/Catalent deal | pharmaphorum
Jan 18, 2025 · US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give Novo Nordisk control of manufacturing facilities currently operated...